Sequencing of bisulfite-treated DNA from these samples shows that there is no significant difference in methylation of the ELA2 promoter region between normal and CML lin-CD34+ cells (Figure 6). The gene discussed is ELANE; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.